MAM Consortium Presentation by Andrew Mahan, Janssen: Comprehensive Characterization of mAbs and Multispecifics with Multiple Technologies, CE, iCIEF-MS and Novel Alternative Fragmentation
MAM Consortium Presentation by Andrew Mahan, Janssen: Comprehensive Characterization of mAbs and Multispecifics with Multiple Technologies, CE, iCIEF-MS and Novel…